Show Notes
In this episode of On The Line, BioCanRx President and CEO Stephanie Michaud joins Matt Gurney for a conversation about one of the biggest problems facing Canadian health care: Canada produces world-class medical research, but too often struggles to turn those discoveries into treatments that actually reach Canadian patients. Stephanie explains why it can take so long for the newest and most promising therapies to make their way into the Canadian healthcare system — and why so much science de...
More from The Line
In the latest episode of The Line Podcast, Matt Gurney returns from a leave to care for his wife and wonders if he’s missed anything over the last two weeks. Turns out he has. It’s his first chance to sit down with Jen Gerson and talk about the Alberta referendum, and Jen — finally having gotten some sleep — offers her concluding thoughts on … all that. Matt gives his reactions and asks Jen a fairly basic question: what, exactly, was the point of the whole exercise? They agree that Danielle S...
In this episode of On The Line, host Jen Gerson speaks with Patrick Lennox, author of On Treason, a new book examining the moral and political consequences of betraying one's own country. Their conversation focuses on Alberta's separatist movement, its reported efforts to secure American recognition for a future independent state, and why Lennox believes the movement represents something more troubling than ordinary regional grievance politics. This episode is brought to you by BioCanRx. We'v...
In the latest episode of The Line Podcast, Jen Gerson is joined by Andrew Potter to discuss Alberta's looming separation referendum, Canada's increasingly complicated relationship with American politics, and whether Pierre Poilievre has any realistic plan to get the Conservatives back in the game. This episode is brought to you by BioCanRx. We’ve been partnering with federally-funded Canadian not-for-profit BioCanRx to learn how made-in-Canada immunotherapies offer new ways to beat cancer. Th...
In today’s episode of On The Line, Gregory Jack, Senior Vice President of Public Affairs at Ipsos Canada, joins Matt Gurney to discuss the growing list of challenges facing Prime Minister Mark Carney — and, for a change, almost none of them have anything to do with Donald Trump or the United States. This episode is brought to you by BioCanRx. We've been partnering with federally-funded Canadian not-for-profit BioCanRx to learn how made-in-Canada immunotherapies offer new ways to beat cancer. ...
In this episode of On The Line, Jen Gerson speaks with Corey Hogan, Liberal MP for Calgary Confederation, about Alberta’s separatist referendum, the federal government’s changing approach to the province, and whether Ottawa’s newfound enthusiasm for getting major projects built represents a substantive shift or simply a change in political messaging. This episode is brought to you by BioCanRx. We've been partnering with federally-funded Canadian not-for-profit BioCanRx to learn how made-in-Ca...